Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Instagram Outage Disrupts Thousands of U.S. Users 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
REDWOOD CITY, Calif., Aug. 31, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September:
- BioCentury 24th Annual NewsMakers in the Biotech Industry Conference on Friday, September 8, 2017 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time). The conference is being held at the Millennium Broadway Hotel & Conference Center in New York City;
- Rodman & Renshaw 19th Annual Global Investment Conference on Monday, September 11, 2017 at 5:05 p.m. Eastern time (2:05 p.m. Pacific time). The conference is being held at the New York Palace Hotel in New York City;
- 2017 KeyBanc Capital Market’s Basic Materials & Packaging Conference on Wednesday, September 13, 2017 at the InterContinental Boston; and
- Janney Montgomery Scott’s Bioproduction & Biostorage Forum on Tuesday, September 19, 2017 at the Union League Club in New York City.
A live webcast and replay of the presentations at the NewsMakers and Rodman & Renshaw Conferences will be available on the Investors section of the company's website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
Contacts: Investors LHA Investor Relations Jody Cain (310) 691-7100 [email protected] Media SCORR Marketing Lea Studer (308) 237-5567 [email protected]
